Role of inflammatory mediators RAGE, sRAGE for developing atherosclerosis in patients with Diabetes Mellitus
Not Applicable
- Conditions
- Health Condition 1: I259- Chronic ischemic heart disease, unspecified
- Registration Number
- CTRI/2024/08/072105
- Lead Sponsor
- GB Pant Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with confirmed cases of Atherosclerosis with Coronary Angiography with more than 50% stenosis in atleast one vessel
Exclusion Criteria
Patients with Acute Coronary Syndrome such as Myocardial Infarction and Patients with Cardiac diseases such as Valvular diseases and Cardiomyopathy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of RAGE and sRAGE in Coronary artery disease patients with and without diabetes mellitusTimepoint: 1 YEAR
- Secondary Outcome Measures
Name Time Method RAGE gene expression and its correlation with blood levels of RAGE and sRAGE and patient phenotype in above patient groupsTimepoint: 1 year